Expert Insights on the Management of Lung Cancer: A Podcast Series

About Expert Insights on the Management of Lung Cancer: A Podcast Series

The treatment landscape of lung cancer has drastically expanded over the last few years, adding novel drug classes and new combinations across the spectrum of disease. Because of this influx of data, oncologists and other clinicians involved in the care of patients with lung cancer are constantly challenged to stay current. Therefore, oncologists and other clinicians need additional education to improve their knowledge of the latest data and guidance for clinical practice. This series of 3 podcasts focusing on HER2-mutated non-small cell lung cancer (NSCLC), KRAS-mutated NSCLC, and malignant pleural mesothelioma is intended to provide information on the latest advancements and practical considerations for clinicians.

Publisher

Medscape

Category

health & fitness · health & fitness

Language

en

Explicit

No

First episode

17 Dec 2021

Latest episode

4 Jan 2022

Latest episodes

3 episodes in the feed.

1. 

   4 Jan 2022

   What's on the Horizon for KRAS-Mutated NSCLC?

   Dr Weiss and Dr Liu discuss the latest developments in KRAS-mutated NSCLC. Credit available for this activity expires: [01/04/23] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965324?src=mkm_podcast_addon_965324

2. 

   23 Dec 2021

   Advances in the Management of MPM: Are You Up to Date?

   Join Dr Dagogo-Jack and Dr Liu as they discuss the management of malignant pleural mesothelioma. Credit available for this activity expires: 12/21/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/964896?src=mkm_podcast_series_964896

3. 

   17 Dec 2021

   What's New in HER2? Evaluating the Evidence in Non-Small Cell Lung Cancer

   Dr Felip and Dr Liu discuss the latest developments and practical considerations in HER2-mutated non-small cell lung cancer. Credit available for this activity expires: 12/15/22 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/964497?src=mkm_podcast_addon_964497